SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-21-001257
Filing Date
2021-12-06
Accepted
2021-12-06 16:25:16
Documents
2
Group Members
ORBIMED CAPITAL GP VI LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 ss659988_sc13ga.htm SC 13G/A 63816
2 JOINT FILING AGREEMENT ss659988_ex99a.htm EX-99.A 7803
  Complete submission text file 0000947871-21-001257.txt   73246
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48459 | Film No.: 211473468
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G/A